PPI Cases To Proceed as Per The New Deadlines Ordered

Introduction

Going forward, Proton Pump Inhibitor (PPI) cases will follow a number of new deadlines ordered by the federal court post the 5th Case Management Conference scheduled this November. Nearly 300 PPI cases are filed in the District of New Jersey by patients who developed renal issues allegedly linked to PPI usage. The drugs include Nexium, Prilosec, PrevAcid, and others.

Allegations hurled by the plaintiffs include that the defendants knew of the kidney failure and other kidney complications, yet failed to provide the patients and doctors with appropriate warnings.

All federally-filed PPI lawsuits were centralized in the District of New Jersey, for coordinated discovery and other pretrial proceedings in August, earlier this year, before Judge Claire C. Cecchi.

Comments

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid…

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

PPI Cases To Proceed as Per The New Deadlines Ordered